Your browser doesn't support javascript.
loading
Recurrent Fanconi Syndrome Induced by Lenalidomide: A Case Report.
Sharra, Irida; Lhoir, Marine; Des Grottes, Jean-Marin; Vaes, Melanie; Guerisse, Fabien.
Affiliation
  • Sharra I; Emergency Department, CHU Charleroi-Chimay, Charleroi, BEL.
  • Lhoir M; Emergency Department, CHU Charleroi-Chimay, Charleroi, BEL.
  • Des Grottes JM; Nephrology Department, CHU Tivoli, La Louvière, BEL.
  • Vaes M; Hematology Department, Chu Tivoli, La Louvière, BEL.
  • Guerisse F; Emergency Department, CHU Charleroi-Chimay, Charleroi, BEL.
Cureus ; 16(8): e66118, 2024 Aug.
Article in En | MEDLINE | ID: mdl-39108773
ABSTRACT
Fanconi syndrome (FS) is a complex disorder characterized by a reabsorption defect in the proximal renal tubule (PT), leading to urinary loss of molecules such as glucose, phosphate, calcium, amino acids, bicarbonate, potassium, and low-molecular-weight proteins. Its etiology can be genetic or acquired, with drug toxicity being a significant cause of the acquired forms. The heterogeneous manifestations of FS, whether in its partial or complete form, can pose challenges in the emergency department; nevertheless, it should be considered in certain patients, as understanding its cause is crucial for initiating effective treatment. We present the case of a 59-year-old female patient with FS who was treated with lenalidomide in the context of stage III IgG kappa multiple myeloma according to the Salmon Durie classification. We highlight the recurrent nature of this syndrome in this patient.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Country of publication: